Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Publication ,  Journal Article
Maze, D; Arcasoy, MO; Henrie, R; Cerquozzi, S; Kamble, R; Al-Hadidi, S; Yacoub, A; Singh, AK; Elsawy, M; Sirhan, S; Smith, E; Marcoux, C ...
Published in: Bone Marrow Transplant
February 2024

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Bone Marrow Transplant

DOI

EISSN

1476-5365

Publication Date

February 2024

Volume

59

Issue

2

Start / End Page

295

Location

England

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Maze, D., Arcasoy, M. O., Henrie, R., Cerquozzi, S., Kamble, R., Al-Hadidi, S., … Gupta, V. (2024). Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study. Bone Marrow Transplant, 59(2), 295. https://doi.org/10.1038/s41409-023-02194-y
Maze, Dawn, Murat O. Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble, Samer Al-Hadidi, Abdulraheem Yacoub, et al. “Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.Bone Marrow Transplant 59, no. 2 (February 2024): 295. https://doi.org/10.1038/s41409-023-02194-y.
Maze D, Arcasoy MO, Henrie R, Cerquozzi S, Kamble R, Al-Hadidi S, et al. Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study. Bone Marrow Transplant. 2024 Feb;59(2):295.
Maze, Dawn, et al. “Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.Bone Marrow Transplant, vol. 59, no. 2, Feb. 2024, p. 295. Pubmed, doi:10.1038/s41409-023-02194-y.
Maze D, Arcasoy MO, Henrie R, Cerquozzi S, Kamble R, Al-Hadidi S, Yacoub A, Singh AK, Elsawy M, Sirhan S, Smith E, Marcoux C, Viswabandya A, Daly A, Sibai H, McNamara C, Shi Y, Xu W, Lajkosz K, Foltz L, Gupta V. Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study. Bone Marrow Transplant. 2024 Feb;59(2):295.

Published In

Bone Marrow Transplant

DOI

EISSN

1476-5365

Publication Date

February 2024

Volume

59

Issue

2

Start / End Page

295

Location

England

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences